Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Mol Cell Neurosci ; 46(2): 507-15, 2011 Feb.
Article in English | MEDLINE | ID: mdl-21145973

ABSTRACT

Intravitreal injections of recombinant ciliary neurotrophic factor (rCNTF) protect adult rat retinal ganglion cells (RGCs) after injury and stimulate regeneration, an effect enhanced by co-injection with a cAMP analogue (CPT-cAMP). This effect is partly mediated by PKA and associated signaling pathways, but CPT-cAMP also moderates upregulation of suppressor of cytokine signaling (SOCS) pathways after rCNTF injection, which will also enhance the responsiveness of RGCs to this and perhaps other cytokines. We now report that intravitreal injections of CPT-cAMP do not potentiate RGC axonal regeneration when CNTF is expressed via an adeno-associated viral vector (rAAV2), and concomitantly we show that increases in retinal SOCS mRNA expression are less when CNTF is delivered using the vector. We also directly tested the impact of elevated SOCS3 expression on the survival and regeneration of injured adult RGCs by injecting a bicistronic rAAV2-SOCS3-GFP vector into the vitreous of eyes in rats with a peripheral nerve graft sutured onto the cut optic nerve. Overexpression of SOCS3 resulted in an overall reduction in axonal regrowth and almost complete regeneration failure of RGCs transduced with the rAAV2-SOCS3-GFP vector. Furthermore, rAAV2-mediated expression of SOCS3 abolished the normally neurotrophic effects elicited by intravitreal rCNTF injections. In summary, CNTF delivery to the retina using viral vectors may be more effective than bolus rCNTF injections because the gene therapy approach has a less pronounced effect on neuron-intrinsic SOCS repressor pathways. Our new gain of function data using rAAV2-SOCS3-GFP demonstrate the negative impact of enhanced SOCS3 expression on the regenerative potential of mature CNS neurons.


Subject(s)
Axons/metabolism , Ciliary Neurotrophic Factor/administration & dosage , Genetic Therapy/methods , Nerve Regeneration/physiology , Retinal Ganglion Cells/metabolism , Suppressor of Cytokine Signaling Proteins/metabolism , Adenoviridae/genetics , Animals , Ciliary Neurotrophic Factor/genetics , Ciliary Neurotrophic Factor/metabolism , Cyclic AMP/administration & dosage , Cyclic AMP/analogs & derivatives , Female , Gene Expression , Genetic Vectors/genetics , Immunohistochemistry , Intravitreal Injections , Microscopy, Confocal , Nerve Regeneration/drug effects , Neuroprotective Agents/administration & dosage , Optic Nerve Injuries/physiopathology , Optic Nerve Injuries/therapy , Polymerase Chain Reaction , RNA, Messenger/analysis , Rats , Rats, Wistar , Recombinant Proteins/administration & dosage , Retinal Ganglion Cells/drug effects , Suppressor of Cytokine Signaling 3 Protein , Suppressor of Cytokine Signaling Proteins/drug effects , Transduction, Genetic
2.
Exp Neurol ; 223(1): 207-20, 2010 May.
Article in English | MEDLINE | ID: mdl-19646436

ABSTRACT

Reimplantation of avulsed rat lumbar spinal ventral roots results in poor recovery of function of the denervated hind limb muscles. In contrast, reimplantation of cervical or sacral ventral roots is a successful repair strategy that results in a significant degree of regeneration. A possible explanation for this difference could be that following lumbar root avulsion, axons have to travel longer distances towards their target muscles, resulting in prolonged denervation of the distal nerve and a diminished capacity to support regeneration. Here we present a detailed spatio-temporal analysis of motoneuron survival, axonal regeneration and neurotrophic factor expression following unilateral avulsion and implantation of lumbar ventral roots L3, L4, and L5. Reimplantation prolongs the survival of motoneurons up to one month post-lesion. The first regenerating motor axons entered the reimplanted ventral roots during the first week and large numbers of fibers gradually enter the lumbar plexus between 2 and 4 weeks, indicating that axons enter the reimplanted roots and plexus over an extended period of time. However, motor axon counts show that relatively few axons reach the distal sciatic nerve in the 16 week post-lesion period. The observed initial increase and subsequent decline in expression of glial cell line-derived neurotrophic factor and brain-derived neurotrophic factor correlate with the apparent spatio-temporal decline in the regenerative capacity of motor axons, indicating that the distal nerve is losing its capacity to support regenerating motor axons following prolonged denervation. These findings have important implications for future strategies to promote long-distance regeneration through distal, chronically denervated peripheral nerves.


Subject(s)
Gene Expression Regulation/physiology , Motor Neurons/pathology , Nerve Growth Factors/metabolism , Nerve Regeneration/physiology , Radiculopathy , Replantation/methods , Animals , Cell Survival/physiology , Choline O-Acetyltransferase/metabolism , Disease Models, Animal , Enzyme-Linked Immunosorbent Assay/methods , Female , Hindlimb/pathology , Lumbosacral Plexus/pathology , Lumbosacral Plexus/physiopathology , Muscle, Skeletal/physiopathology , Nerve Growth Factors/genetics , Radiculopathy/pathology , Radiculopathy/physiopathology , Radiculopathy/surgery , Rats , Rats, Wistar , Sciatic Nerve/metabolism , Sciatic Nerve/pathology , Time Factors
3.
Gene Ther ; 16(4): 521-32, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19092858

ABSTRACT

Recombinant adeno-associated virus (rAAV) vectors are increasingly being used as tools for gene therapy, and clinical trials have begun in patients with genetically linked retinal disorders. Intravitreal injection is optimal for the transduction of retinal ganglion cells (RGCs), although complete selectivity has not been achieved. There may also be advantages in using intravitreal approaches for the transduction of photoreceptors. Here we compared the cellular tropism and transduction efficiency of rAAV2/1, -2/2, -2/3, -2/4, -2/5, -2/6 and -2/8 in adult rat retina after intravitreal injection. Each vector encoded green fluorescent protein (GFP), and the number, laminar distribution and morphology of transduced GFP(+) cells were determined using fluorescent microscopy. Assessment of transduced cell phenotype was based on cell morphology and immunohistochemistry. rAAV2/2 and rAAV2/6 transduced the greatest number of cells, whereas rAAV2/5 and rAAV2/8 were least efficient. Most vectors primarily transduced RGCs; however, rAAV2/6 had a more diverse tropism profile, with 46% identified as amacrine or bipolar cells, 23% as RGCs and 22% as Müller cells. Müller cells were also frequently transduced by rAAV2/4. The highest photoreceptor transduction was seen after intravitreal rAAV2/3 injection. These data facilitate the design and selection of rAAV vectors to target specific retinal cells, potentially leading to an improved gene therapy for various human retinal pathologies.


Subject(s)
Dependovirus/genetics , Genetic Vectors/administration & dosage , Retina/metabolism , Transduction, Genetic , Animals , Dependovirus/classification , Dependovirus/physiology , Female , Injections, Intraocular , Microscopy, Confocal , Rats , Rats, Wistar , Retina/virology , Serotyping , Viral Tropism , Vitreous Body
4.
Proc Natl Acad Sci U S A ; 95(4): 1466-71, 1998 Feb 17.
Article in English | MEDLINE | ID: mdl-9465038

ABSTRACT

A recently cloned isoform of cGMP-dependent protein kinase (cGK), designated type II, was implicated as the mediator of cGMP-provoked intestinal Cl- secretion based on its localization in the apical membrane of enterocytes and on its capacity to activate cystic fibrosis transmembrane conductance regulator (CFTR) Cl- channels. In contrast, the soluble type I cGK was unable to activate CFTR in intact cells, although both cGK I and cGK II could phosphorylate CFTR in vitro. To investigate the molecular basis for the cGK II isotype specificity of CFTR channel gating, we expressed cGK II or cGK I mutants possessing different membrane binding properties by using adenoviral vectors in a CFTR-transfected intestinal cell line, and we examined the ability of cGMP to phosphorylate and activate the Cl- channel. Mutation of the cGK II N-terminal myristoylation site (Gly2 --> Ala) reduced cGK II membrane binding and severely impaired cGK II activation of CFTR. Conversely, a chimeric protein, in which the N-terminal membrane-anchoring domain of cGK II was fused to the N terminus of cGK Ibeta, acquired the ability to associate with the membrane and activate the CFTR Cl- channel. The potency order of cGK constructs for activation of CFTR (cGK II > membrane-bound cGK I chimer >> nonmyristoylated cGK II > cGK Ibeta) correlated with the extent of 32P incorporation into CFTR observed in parallel measurements. These results strongly support the concept that membrane targeting of cGK is a major determinant of CFTR Cl- channel activation in intact cells.


Subject(s)
Chloride Channels/physiology , Cyclic GMP-Dependent Protein Kinases/metabolism , Cystic Fibrosis Transmembrane Conductance Regulator/genetics , Animals , Cell Compartmentation , Cell Membrane/enzymology , Humans , Ion Channel Gating , Myristates , Phosphorylation , Protein Processing, Post-Translational , Rats , Recombinant Proteins , Transfection
5.
J Biol Chem ; 271(12): 7025-9, 1996 Mar 22.
Article in English | MEDLINE | ID: mdl-8636133

ABSTRACT

The apical membrane of intestinal epithelial cells harbors a unique isozyme of cGMP-dependent protein kinase (cGK type II) which acts as a key regulator of ion transport systems, including the cystic fibrosis transmembrane conductance regulator (CFTR)-chloride channel. To explore the mechanism of cGK II membrane-anchoring, recombinant cGK II was expressed stably in HEK 293 cells or transiently in COS-1 cells. In both cell lines, cGK II was found predominantly in the particulate fraction. Immunoprecipitation of solubilized cGK II did not reveal any other tightly associated proteins, suggesting a membrane binding motif within cGK II itself. The primary structure of cGK II is devoid of hydrophobic transmembrane domains; cGK II does, however, contain a penultimate glycine, a potential acceptor for a myristoyl moiety. Metabolic labeling showed that cGK II was indeed able to incorporate [3H]myristate. Moreover, incubation of cGK II-expressing 293 cells with the myristoylation inhibitor 2-hydroxymyristic acid (1 mM) significantly increased the proportion of cGK II in the cytosol from 10 +/- 5 to 35 +/- 4%. Furthermore, a nonmyristoylated cGK II Gly2 --> Ala mutant was localized predominantly in the cytosol after transient expression in COS-1 cells. The absence of the myristoyl group did not affect the specific enzyme activity or the Ka for cGMP and only slightly enhanced the thermal stability of cGK II. These results indicate that N-terminal myristoylation fulfills a crucial role in directing cGK II to the membrane.


Subject(s)
Cyclic GMP-Dependent Protein Kinases/metabolism , Isoenzymes/metabolism , Myristic Acids/metabolism , Animals , Base Sequence , Cell Line , Cell Membrane/enzymology , DNA Primers , Humans , Lipid Metabolism , Molecular Sequence Data , Myristic Acid , Substrate Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...